What is he best known for?
The fields of study he is best known for:
- Enzyme
- Internal medicine
- Biochemistry
His main research concerns Thrombin, Protein C, Internal medicine, Endocrinology and Biochemistry.
Jan Rosing combines subjects such as Peptide bond, Phospholipid and Tissue factor with his study of Thrombin.
His Protein C research incorporates themes from Molecular biology, Factor V, Cofactor and Pharmacology.
He has researched Factor V in several fields, including Coagulopathy and Immunology.
His Endocrinology research is multidisciplinary, incorporating elements of Anticoagulant and Venous thrombosis, Activated protein C resistance, Factor V Leiden.
His studies deal with areas such as Biophysics, Prothrombinase and Thromboplastin as well as Biochemistry.
His most cited work include:
- The role of phospholipids and factor Va in the prothrombinase complex. (567 citations)
- The role of phospholipid and factor VIIIa in the activation of bovine factor X. (487 citations)
- Oral contraceptives and the risk of venous thrombosis (451 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Protein C, Internal medicine, Thrombin, Biochemistry and Endocrinology.
The Protein C study combines topics in areas such as Molecular biology, Factor V, Immunology and Factor V Leiden.
His study in the fields of Activated protein C resistance, Venous thrombosis and Risk factor under the domain of Internal medicine overlaps with other disciplines such as Levonorgestrel.
His Thrombin research incorporates elements of Activator and Tissue factor.
In his research on the topic of Biochemistry, Thrombomodulin and Thrombin generation is strongly related with Coagulation.
His Endocrinology study integrates concerns from other disciplines, such as Anticoagulant and Antithrombin.
He most often published in these fields:
- Protein C (35.71%)
- Internal medicine (33.93%)
- Thrombin (31.70%)
What were the highlights of his more recent work (between 2007-2021)?
- Internal medicine (33.93%)
- Tissue factor pathway inhibitor (14.73%)
- Endocrinology (28.57%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Tissue factor pathway inhibitor, Endocrinology, Protein C and Thrombin.
His work in the fields of Activated protein C resistance, Venous thrombosis and Risk factor overlaps with other areas such as Levonorgestrel.
His Tissue factor pathway inhibitor research integrates issues from Protein S, Hemophilias, Biochemistry and Factor V.
The concepts of his Endocrinology study are interwoven with issues in Blood coagulation test and Coagulopathy.
His Protein C study combines topics from a wide range of disciplines, such as Thrombophilia and Factor V Leiden.
Thrombin is a subfield of Immunology that Jan Rosing studies.
Between 2007 and 2021, his most popular works were:
- Mechanisms of Estrogen-Induced Venous Thromboembolism (125 citations)
- Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. (118 citations)
- Thrombin generation tests (111 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Gene
Jan Rosing spends much of his time researching Internal medicine, Tissue factor pathway inhibitor, Endocrinology, Tissue factor and Protein C.
Jan Rosing usually deals with Tissue factor pathway inhibitor and limits it to topics linked to Biochemistry and Factor Xa Inhibitor and Function.
His Endocrinology study combines topics in areas such as Blood coagulation test and Risk factor.
Jan Rosing interconnects Protein domain, Coagulopathy, Thrombin and Peptide in the investigation of issues within Tissue factor.
His research on Thrombin concerns the broader Immunology.
He is studying Protein S, which is a component of Protein C.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
